Novel Early Warning System for Hypoglycaemia. An innovative technique will be developed for early detection of low blood glucose level (hypoglycaemia), a life-threatening complication affecting millions of people with Type 1 diabetes worldwide. Real-time analysis of the effectiveness of skin impedance, ECG (in particular heart rate and QT interval), and EEG (alpha wave) will be combined with robust adaptive neural networks to provide a novel theoretical and practical basis for developing a non-i ....Novel Early Warning System for Hypoglycaemia. An innovative technique will be developed for early detection of low blood glucose level (hypoglycaemia), a life-threatening complication affecting millions of people with Type 1 diabetes worldwide. Real-time analysis of the effectiveness of skin impedance, ECG (in particular heart rate and QT interval), and EEG (alpha wave) will be combined with robust adaptive neural networks to provide a novel theoretical and practical basis for developing a non-invasive hypoglycaemia monitor. This device has the potential to save lives, improve quality of life for people with diabetes and their carers, and put Australia at the forefront in this $US5 billion pa industry.Read moreRead less
Innovative hands-free technology to give the severely disabled greater mobility control. Half of the serious neurological injuries in Australia result in tetraplegia. Combined with other disabilities that involve severe mobility impairments the cost to the community economically, psychologically and socially is huge. This new Australian technology will facilitate effective sharing of control between a disabled person and a computer control system, taking advantage of their unique strengths and e ....Innovative hands-free technology to give the severely disabled greater mobility control. Half of the serious neurological injuries in Australia result in tetraplegia. Combined with other disabilities that involve severe mobility impairments the cost to the community economically, psychologically and socially is huge. This new Australian technology will facilitate effective sharing of control between a disabled person and a computer control system, taking advantage of their unique strengths and enabling each to aid the other in areas of weakness. The social and personal benefits are potentially very large. Scope also exists to significantly reduce healthcare costs and to develop a new industry in hands-free technology.Read moreRead less
Enhancing the independence of the severely disabled: Improving the detection rates of an EEG based brain computer interface (BCI). Severe disability costs the Australian economy and society billions of dollars each year and the population of severely disabled is steadily increasing. Also, disability results in impairments that can traumatically alter a person's life. The outcomes of this project will result in substantial national benefits by (i) optimising technology that will greatly improve t ....Enhancing the independence of the severely disabled: Improving the detection rates of an EEG based brain computer interface (BCI). Severe disability costs the Australian economy and society billions of dollars each year and the population of severely disabled is steadily increasing. Also, disability results in impairments that can traumatically alter a person's life. The outcomes of this project will result in substantial national benefits by (i) optimising technology that will greatly improve the life of the disabled by enhancing their ability to control their environment, (ii) situating Australia in the forefront of disability technology research and development, and (iii) enhancing the development of knowledge in research training students in the biomedical area. Read moreRead less
New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required ....New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required dimensional stability, impermeability and wear resistance. Following sophisticated experiments of modified materials, the best candidates will be used in prototype devices, for final selection of the optimal materials for the new device.Read moreRead less
Hydrogel systems for effective encapsulation of functional pancreatic islet cells. This proposal addresses the problem of maintaining viability and function of cells encapsulated within an immuno-isolation barrier material. The research will develop biosynthetic materials that are able to meet design criteria for an effective biomaterial for this application. The major benefits to Australia will be in improved health outcomes by providing safer, more efficacious materials, economic growth develo ....Hydrogel systems for effective encapsulation of functional pancreatic islet cells. This proposal addresses the problem of maintaining viability and function of cells encapsulated within an immuno-isolation barrier material. The research will develop biosynthetic materials that are able to meet design criteria for an effective biomaterial for this application. The major benefits to Australia will be in improved health outcomes by providing safer, more efficacious materials, economic growth development of the Australian Medical Device industry and in high level training of researchers in this field.Read moreRead less
Modelling and Measurement of Flow-Structure Dynamics in the Human Upper Airway. Sleep disruption due to the common and disabling conditions of snoring and obstruction of the human upper airway can result in chronic fatigue, lost work and accidents caused by daytime drowsiness. To date the behaviour of the upper airway has not been adequately studied in terms able to reveal the mechanical causes of these conditions. This deficiency is addressed through the development and use of simulation tools ....Modelling and Measurement of Flow-Structure Dynamics in the Human Upper Airway. Sleep disruption due to the common and disabling conditions of snoring and obstruction of the human upper airway can result in chronic fatigue, lost work and accidents caused by daytime drowsiness. To date the behaviour of the upper airway has not been adequately studied in terms able to reveal the mechanical causes of these conditions. This deficiency is addressed through the development and use of simulation tools and measurement techniques that will elucidate the flow-structure dynamics leading to new diagnostic and improved treatment methods. Simulating the effect of treatment on any individual will permit it to be chosen to maximise its efficacy for a problem that costs the nation an estimated $2 Billion per year in lost productivity.Read moreRead less
Novel computational tools for the analysis of sympathetic nervous system activity. This project will investigate electrical signals from the heart, resulting in novel tools for the assessment of sympathetic nervous system activity. The findings will contribute to advancing Australia's international leading position in health technology and improve community health.
Noval design of a Bi-Ventricular Assist Device (BVAD) Centrifugal Heart Pump as an Implantable Total Artificial Heart. In Australia, 40%(50,797) of all deaths each year are related to heart disease and accounted for 12% (A$4Billion) of total recurrent health expenditure. This innovative research aims at developing a single biventricular assist device (BVAD) driven by a magnetically suspended double-sided centrifugal pump impeller. Current techniques require two implantable devices, thus preventi ....Noval design of a Bi-Ventricular Assist Device (BVAD) Centrifugal Heart Pump as an Implantable Total Artificial Heart. In Australia, 40%(50,797) of all deaths each year are related to heart disease and accounted for 12% (A$4Billion) of total recurrent health expenditure. This innovative research aims at developing a single biventricular assist device (BVAD) driven by a magnetically suspended double-sided centrifugal pump impeller. Current techniques require two implantable devices, thus preventing smaller patients from access to BVAD technology. The expected outcomes will be a significantly small and compact device and provide an alternative to open-heart transplantation, thus helping to alleviate the demand on donor hearts, as well as the strain on the Australian Heath Care System caused by cardiovascular disease.Read moreRead less
The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the heal ....The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the health and well-being of Australians. The research falls within the Designated National Research Priority of Frontier Technologies for Building and Transforming Australian Industries.Read moreRead less
Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasm ....Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasma, which is the current agent used to treat patients with AAT-misfolding disease.Read moreRead less